Endurant Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-81,007
Closed -$2.59M 69
2022
Q2
$2.59M Buy
81,007
+37,757
+87% +$1.21M 0.91% 26
2022
Q1
$1.5M Buy
43,250
+453
+1% +$15.7K 0.39% 44
2021
Q4
$1.25M Buy
+42,797
New +$1.25M 0.3% 51